Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04057638 · ClinicalTrials.gov registry record · NA

Craniomaxillofacial and Upper Extremity Allotransplantation

A NA study of Hand Injuries and Facial Injuries, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04057638 is a NA study of Hand Injuries and Facial Injuries that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 10 participants, below the 41-participant average among 5 other Hand Injuries trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04057638, a NA study of Hand Injuries and Facial Injuries, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate functional and aesthetic outcomes of combined facial and upper extremity composite tissue allografts on patients who have not achieved functional and aesthetic outcomes with conventional reconstructive surgical strategies and prosthetic devices.

Interventions

  • PROCEDURE Combined Craniomaxillofacial and Upper Extremity Allotransplantation

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-06-17
Est. Completion 2026-01-01
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT04057638

The ClinicalTrials.gov registry entry for NCT04057638 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 41-participant average among 5 other Hand Injuries trials with a reported enrollment target (76% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Hand Injuries appearing as the primary indexed condition, and to 1 intervention - of which Combined Craniomaxillofacial and Upper Extremity Allotransplantation is the first listed.

NCT04057638 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04057638 about?

NCT04057638 is a clinical study titled "Craniomaxillofacial and Upper Extremity Allotransplantation". The purpose of this study is to evaluate functional and aesthetic outcomes of combined facial and upper extremity composite tissue allografts on patients who have not achieved functional and aesthetic outcomes with conventional reconstructive surgical strategies and prosthetic devices.

What is the current status of trial NCT04057638?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2019-06-17. Estimated completion is 2026-01-01.

What conditions does trial NCT04057638 study?

This clinical trial studies the following conditions: Hand Injuries, Facial Injuries, Craniofacial Injuries, Facial Deformity, Face Injuries.

What interventions are being tested in trial NCT04057638?

The interventions under investigation include: Combined Craniomaxillofacial and Upper Extremity Allotransplantation (PROCEDURE).

Who is sponsoring clinical trial NCT04057638?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04057638 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hand Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.